Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 7, 1996, Pages 1311-1321

  Takagi, Hitoshi ^a   King, George L ^a,b   Ferrara, Napoleone ^c   Aiello, Lloyd Paul ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c GENENTECH INC   (United States)

Author keywords

endothelial cell; Flk; KDR; receptor; retina; vascular endothelial growth factor (VEGF); vascular permeability factor (VPF)

Indexed keywords

6 N [2 (3,5 DIMETHOXYPHENYL) 2 (2 METHYLPHENYL)ETHYL]ADENOSINE; 6 N CYCLOPENTYLADENOSINE; ADENOSINE A2 RECEPTOR; GROWTH FACTOR RECEPTOR; MESSENGER RNA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIUM; CATTLE; CELL HYPOXIA; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; RETINA CAPILLARY;

ADENOSINE; ANIMALS; BLOTTING, NORTHERN; CAPILLARIES; CATTLE; CELL HYPOXIA; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; LYMPHOKINES; OXYGEN; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, PURINERGIC P1; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETINAL VESSELS; RNA, MESSENGER; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029884640     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Klein R, Klein BEK. Vision disorders in diabetes. In: Diabetes in America. Bethesda, MD: 1985. US Dept of Health and Human Services publication NIH 85-1468.
2. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders [see comments]. N Engl J Med. 1994;331:1480-1487.
3. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol. 1995; 113:1538-1544.
4. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 1995; 92:905-909.
5. Adamis AP, Shima DT, Yeo KT, et al. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun. 1993; 193:631-638.
6. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994; 145:574-584.
7. Ashton N, Ward B, Serpell G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol. 1954;38:397-432.
8. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK. 1948;68:137-180.
9. Leung, DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitgen. Science. 1989;246:1306-1309.
10. Berse B, Brown LF, Van De Vater L, Dvorak HF Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 1992;2:211-220.
11. Dvorak HF, Sioussat TM, Brown LF, et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exp Med. 1991;174:1275-1278.
12. Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 1986;46:5629-5632.
13. Plate KH, Breier G, Weich HB, Risau W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature. 1992; 359:845-848.
14. Simorre PV, Guerrin M, Chollet P, et al. Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci 1994;35:3393-3400.
15. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factorlevels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445-450.
16. Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara N. Binding site for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest. 1992;89:244-253.
17. Terman BI, Dougher VM, Carrion ME, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun. 1992;187:1579-1586.
18. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 1992;255:989-991.
19. Shibuya M, Yamaguchi S, Yamane A, et al. Nucleotide sequence and expression of a novel receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 1990;5:519-524.
20. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA. 1993; 90:7533-7537.
21. Waltenberger J, Claesson WL, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem. 1994;269:26988-26995.
22. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene. 1995;10:135-47.
23. Thieme H, Aiello LP, Takagi H, Ferrara N, King GL. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes. 1995;44:98-103.
24. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J Clin Invest. 1995;95:1798-1807.
25. Tucker AL, Linden J. Cloned receptors and cardiovascular responses to adenosine. Cardiovasc Res. 1993; 27:62-67.
26. Collis MG, Hourani SMO. Adenosine receptor subtypes. Trends Pharmacol Sci Rev. 1993;14:360-366.
27. Libert F, Parmentier M, Lefort A. Selective amplification and cloning of four new members of the G-protein coupled receptor family. Science. 1989;244:569-572.
28. Katori M, Berne RM. Release of adenosine from anoxic hearts: Relationship to coronary flow. Circ Res. 1966;19:420-425.
29. Bontemps F, Mimouni M, Van den Berghe G. Mechanisms of elevation of adenosine levels in anoxic hepatocytes. J Biochem. 1993;290:671-677.
30. Bontemps F, Mimouni M, Van den Berghe G. Phosphorylation of adenosine in anoxic pericytes by a exchange reaction catalysed by adenosine kinase. J Biochem. 1993;290:679-684.
31. Adair TH, Gay WJ, Montani JP. Growth regulation of the vascular system: Evidence for a metabolic hypothesis. Am J Physiol. 1990;259:R393-R404.
32. Dusseau JW, Hutchins PW, Malbasa DS. Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circ Res. 1986;59:163-170.
33. Teuscher E, Weidlich V. Adenosine nucleltides, adenosine and adenine as angiogenesis factors. Biomed Biochem Acta. 1985;44:493-495.
34. Rathbone MP, Middlemiss PJ, Kim JK, et al. Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells. Nucleosci Res. 1992;13:1-17.
35. Meininger CJ, Schelling ME, Granjer HJ. Adenosine and hypoxia stimulates proliferation and migration of endothelial cells. Am J Physiol. 1988;255:H554-H562.
36. Ethier MF, Chander V, Dobson JG. Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol. 1993;265:H131-H138.
37. Hashimoto E, Kage K, Ogita T, Nakaoka T, Matsuoka R, Kira Y. Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. Biochem Biophys Res Commun. 1994;204:318-24.
38. Fischer S, Sharma HS, Karliczek GF, Schaper W. Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Mol Brain Res. 1995;28:141-148.
39. King GL, Goodman S, Buzney S, Moses A. Receptors and growth promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest. 1985;75:1028-1036.
40. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-PhOH-chloroform extraction. Anal Biochem. 1987;162:156-159.
41. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992;257:967-971.
42. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell lines. Nucleic Acids Res. 1982;10: 7895-7903.
43. Sanders SP, Zweier JL, Kuppusamy SL, et al. Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport. J Clin Invest. 1993;91:46-52.
44. Bruns RF, Lu GH, Pugsley TA. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membrane. Mol Pharmacol 1986;29:331-346.
45. Aiello LP, Pierce EA, Foley ED, et al. Inhibition of vascular endothelial growth factor suppresses retinal neovascularization in vivo. Proc Natl Acad Sci USA. 1995;92:10457-10461.
46. Barleon B, Hauser S, Schollmann C, et al. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells. J Cell Biochem. 1994;54:56-66.
47. Nakashima J, Brookins J, Beckman B, Fisher JW. Increased erythropoietin secretion in human hepatoma cells by N6-cyclohexyladenosine. Am J Physiol. 1991;261:C455-C460.